Administration of a CD31 agonist peptide greatly reduced the incidence of AD in ApoE–/– mice, and was found bind to wound-associated leukocytes, including macrophages (Fornasa et al., 2012; Andreata et al., 2018). The gene discussed is PECAM1; the disease is Alzheimer disease.